MSTN and Duchenne muscular dystrophy: Myostatin downregulation has been reported to increase muscle mass and muscle strength in an mdx mouse model of DMD through the use of myostatin-blocking agents like monoclonal antibodies,32, 33 recombinant myostatin propeptides,34, 35 myostatin antagonists,36, 37 or soluble myostatin receptors.38